NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 89 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q4 2013. The put-call ratio across all filers is 0.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $0 | -100.0% | 1,000 | -96.0% | 0.00% | – |
| Q1 2016 | $22,000 | -67.6% | 25,257 | -51.1% | 0.00% | – |
| Q4 2015 | $68,000 | -84.1% | 51,700 | -72.6% | 0.00% | – |
| Q3 2015 | $428,000 | +35.9% | 188,402 | -4.0% | 0.00% | – |
| Q2 2015 | $315,000 | +24.0% | 196,220 | +22.4% | 0.00% | – |
| Q1 2015 | $254,000 | -15.9% | 160,305 | +0.1% | 0.00% | – |
| Q4 2014 | $302,000 | +12.7% | 160,083 | -21.4% | 0.00% | – |
| Q3 2014 | $268,000 | -7.9% | 203,641 | +2.7% | 0.00% | – |
| Q2 2014 | $291,000 | -41.7% | 198,267 | -26.7% | 0.00% | – |
| Q1 2014 | $499,000 | -6.9% | 270,339 | +4.3% | 0.00% | – |
| Q4 2013 | $536,000 | -46.7% | 259,211 | -31.7% | 0.00% | -100.0% |
| Q3 2013 | $1,005,000 | – | 379,749 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |